Search Ontology:
ChEBI

caspofungin acetate

Term ID
CHEBI:59900
Synonyms
  • (4R,5S)-5-((2-aminoethyl)amino)-N(2)-(10,12-dimethyltetradecanoyl)-4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline cyclic (6-1)-peptide diacetate
  • 1-[(4R,5S)-5-[(2-aminoethyl)amino]-N(2)-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine]-pneumocandin B0 diacetate
  • caspofungin diacetate
  • N-{(2R,6S,9S,11R,12S,14aS,15S,20S,23S,25aS)-12-[(2-aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11,15-trihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2
(all 4)
Definition
The diacetate salt of caspofungin. It is used for the treatment of invasive candidiasis, and of aspergillosis in patients who are refractory to, or intolerant of, other therapy.
References
  • Beilstein:9184764
  • CAS:179463-17-3
  • DrugBank:DB00520
  • KEGG:D02501
(all 4)
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from caspofungin acetate
Phenotype where environments contain caspofungin acetate
Phenotype modified by environments containing caspofungin acetate
Phenotype affecting caspofungin acetate
Human Disease Model